These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 25729879)

  • 21. Embedded effort scales in the repeatable battery for the assessment of neuropsychological status: do they detect neurocognitive malingering?
    Crighton AH; Wygant DB; Holt KR; Granacher RP
    Arch Clin Neuropsychol; 2015 May; 30(3):181-5. PubMed ID: 25673871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of the MoCA test as a screening instrument in multiple sclerosis.
    Dagenais E; Rouleau I; Demers M; Jobin C; Roger E; Chamelian L; Duquette P
    Can J Neurol Sci; 2013 May; 40(3):410-5. PubMed ID: 23603179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity.
    Randolph C; Tierney MC; Mohr E; Chase TN
    J Clin Exp Neuropsychol; 1998 Jun; 20(3):310-9. PubMed ID: 9845158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
    Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
    Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
    AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project.
    Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D
    J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
    Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
    Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological characteristics of cognitive impairment of multiple sclerosis patients in a Latin American country.
    Cáceres F; Vanotti S; Rao S;
    J Clin Exp Neuropsychol; 2011 Dec; 33(10):1094-8. PubMed ID: 21978317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular motor measures of cognitive dysfunction in multiple sclerosis II: working memory.
    Clough M; Mitchell L; Millist L; Lizak N; Beh S; Frohman TC; Frohman EM; White OB; Fielding J
    J Neurol; 2015 May; 262(5):1138-47. PubMed ID: 25851742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional magnetic resonance imaging lesion burden and cognitive function in multiple sclerosis: a longitudinal study.
    Sperling RA; Guttmann CR; Hohol MJ; Warfield SK; Jakab M; Parente M; Diamond EL; Daffner KR; Olek MJ; Orav EJ; Kikinis R; Jolesz FA; Weiner HL
    Arch Neurol; 2001 Jan; 58(1):115-21. PubMed ID: 11176944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The association between cognitive impairment and quality of life in patients with early multiple sclerosis.
    Glanz BI; Healy BC; Rintell DJ; Jaffin SK; Bakshi R; Weiner HL
    J Neurol Sci; 2010 Mar; 290(1-2):75-9. PubMed ID: 19944429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unemployment in multiple sclerosis: the contribution of personality and disease.
    Strober LB; Christodoulou C; Benedict RH; Westervelt HJ; Melville P; Scherl WF; Weinstock-Guttman B; Rizvi S; Goodman AD; Krupp LB
    Mult Scler; 2012 May; 18(5):647-53. PubMed ID: 22183935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
    Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
    J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three screening batteries to detect cognitive impairment in multiple sclerosis.
    Aupperle RL; Beatty WW; Shelton Fde N; Gontkovsky ST
    Mult Scler; 2002 Oct; 8(5):382-9. PubMed ID: 12356204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cognitive disorders in multiple sclerosis: correlations between neuropsychological, neurophysiological and neuroimaging characteristics].
    Alifirova VM; Musina NF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2 Pt 2):57-60. PubMed ID: 23528595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cognitive impairment in the early phase of multiple sclerosis and its relationship with mood, demographic and clinical variables].
    Nieto Barco A; Sánchez López Mdel P; Barroso Ribal J; Olivares Pérez T; Hernández Pérez MA
    Psicothema; 2008 Nov; 20(4):583-8. PubMed ID: 18940054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of immunomodulation on psycho-neuroimmunological functions in benign multiple sclerosis.
    Haase CG; Tinnefeld M; Faustmann PM
    Neuroimmunomodulation; 2004; 11(6):365-72. PubMed ID: 15467351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.